Document Detail

delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.
MedLine Citation:
PMID:  500806     Owner:  NLM     Status:  MEDLINE    
Properties of delta-aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia were investigated with special reference to the protease in mitochondria of erythroblasts. delta-Aminolevulinic acid synthetase activity in erythroblasts of patients with this disease before treatment was extremely decreased, whereas it gradually increased in parallel with the improvement of anemia by the therapy with pyridoxal phosphate. The amount of apo-delta-aminolevulinic acid synthetase in erythroblasts before treatment was also extremely diminished. Apparent affinity to pyridoxal phosphate of the apo-delta-aminolevulinic acid synthetase obtained from erythroblasts of the patients was almost the same as that of normal controls. The activity of a new protease which is considered to be engaged in the regulation of delta-aminolevulinic acid synthetase levels in mitochondria of erythroblasts was shown to be in normal range in erythroblasts of the patients. On the other hand, apo-delta-aminolevulinic acid synthetase obtained from the patients was extremely sensitive to the protease. These results indicate that disturbance of heme synthesis characteristic to pyridoxine-responsive anemia could be ascribed to the hypercatabolism of delta-aminolevulinic acid synthetase caused by the increased susceptibility to the controlling protease in erythroblasts.
Y Aoki; S Muranaka; K Nakabayashi; Y Ueda
Related Documents :
16172016 - Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynami...
8482866 - Helisoma duryi: its present range of distribution and implications with schistosomiasis...
1147896 - Some observations on chlorophyll(ide) synthesis by isolated etioplasts.
10956126 - Role of carbonyl compounds in so(2) binding phenomena in musts and wines from botrytize...
16425316 - Simultaneous determination of essential basic amino acids in pharmaceuticals by capilla...
266486 - Isolation, characterization and nature of carbohydrate-peptide linkage of an alkali-ext...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  64     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  1979 Nov 
Date Detail:
Created Date:  1980-01-28     Completed Date:  1980-01-28     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1196-203     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
5-Aminolevulinate Synthetase / metabolism*
Anemia, Hypochromic / drug therapy,  enzymology*
Anemia, Sideroblastic / drug therapy,  enzymology*
Bone Marrow / enzymology*,  ultrastructure
Bone Marrow Cells
Endopeptidases / metabolism
Enzyme Inhibitors / metabolism
Mitochondria / enzymology*
Pyridoxal Phosphate / therapeutic use
Vitamin B 6 Deficiency / drug therapy,  metabolism
Reg. No./Substance:
0/Enzyme Inhibitors; 54-47-7/Pyridoxal Phosphate; EC Synthetase; EC 3.4.-/Endopeptidases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hormonal stimulation of erythropoietin production and erythropoiesis in anephric sheep fetuses.
Next Document:  Mesangial function in ureteral obstruction in the rat. Blockade of the efferent limb.